Authors :
Mehek Isharani
Volume/Issue :
Volume 8 - 2023, Issue 9 - September
Google Scholar :
https://tinyurl.com/5h28353u
Scribd :
https://tinyurl.com/4txhb2hm
DOI :
https://doi.org/10.5281/zenodo.8420260
Abstract :
Multiple Myeloma, a rare and complex form of
blood cancer, presents significant challenges in both
diagnosis and treatment. This malignancy arises from
malfunctioning plasma cells and is characterized by
excessive monoclonal immunoglobulin production,
leading to damage to vital organs. Despite advances in
cancer research and substantial funding, the disease
remains difficult to detect in its early stages. Current
treatment options, including chemotherapy, steroids, and
stem cell transplantation, are associated with notable side
effects. However, the emergence of CRISPR-based
genome editing technology offers promising avenues for
personalized treatment and novel research approaches,
though concerns about off-target effects have slowed
clinical adoption. As the battle against Multiple Myeloma
continues, CRISPR represents a beacon of hope for more
effective and precise interventions in the future. This
study aims to explore the disease, the effect of the current
treatments, and the possible impact CRISPR may have on
finding a cure for the disease and changing the course of
treatment.
Multiple Myeloma, a rare and complex form of
blood cancer, presents significant challenges in both
diagnosis and treatment. This malignancy arises from
malfunctioning plasma cells and is characterized by
excessive monoclonal immunoglobulin production,
leading to damage to vital organs. Despite advances in
cancer research and substantial funding, the disease
remains difficult to detect in its early stages. Current
treatment options, including chemotherapy, steroids, and
stem cell transplantation, are associated with notable side
effects. However, the emergence of CRISPR-based
genome editing technology offers promising avenues for
personalized treatment and novel research approaches,
though concerns about off-target effects have slowed
clinical adoption. As the battle against Multiple Myeloma
continues, CRISPR represents a beacon of hope for more
effective and precise interventions in the future. This
study aims to explore the disease, the effect of the current
treatments, and the possible impact CRISPR may have on
finding a cure for the disease and changing the course of
treatment.
